Breaking
Friday, June 19, 2026

Regulatory Updates

🇺🇸 FDA Page 31

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.

Showing 361–372 of 373 articles

High impact NewsApr 11, 2026

FDA Approves VitaRestore: New Treatment for Age-Related Macular Degeneration

FDA · Age-Related Macular Degeneration · 6 min

Dr. Sarah Mitchell
High impact NewsApr 11, 2026

FDA Approves NasoClear: First Nasal Spray for Pediatric RSV

FDA · Pediatric Infectious Diseases · 6 min

Dr. Sarah Mitchell
High impact NewsApr 10, 2026

FDA Approves Revitalize: Breakthrough for Chronic Fatigue Syndrome

FDA · Chronic Fatigue Syndrome · 6 min

Dr. Sarah Mitchell
High impact AnalysisApr 10, 2026

Blockchain in Pharmaceutical Supply Chain: Ensuring Drug Safety with FDA Insights

FDA · 10 min

Dr. Sarah Mitchell
High impact NewsApr 8, 2026

FDA Approves Dupixent for Eosinophilic Esophagitis Treatment

FDA · Eosinophilic Esophagitis · 4 min

Dr. Sarah Mitchell
High impact NewsApr 8, 2026

FDA Approves Stelara: New Ulcerative Colitis Treatment from J&J

FDA · Ulcerative Colitis · 4 min

Dr. Sarah Mitchell
High impact NewsApr 8, 2026

FDA Approves Trikafta for Cystic Fibrosis in Children Ages 2-5

FDA · cystic fibrosis · 4 min

Dr. Sarah Mitchell
High impact NewsApr 6, 2026

FDA Approves RapidClot: Tranexamic Acid for Trauma Bleeding

FDA · Trauma Hemorrhage Management · 4 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Approves Repatha for Pediatric Heterozygous Familial Hypercholesterolemia

FDA · cardiology · 4 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Approves Adzynma: New Treatment for Thrombotic Thrombocytopenic Purpura

FDA · Hematology · 6 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Approves Veozah: New Non-Hormonal Menopause Treatment

FDA · Menopause · 4 min

Dr. Sarah Mitchell
High impact AnalysisApr 1, 2026

CAR-T Cell Therapy Advancements and FDA Regulatory Pathways 2024

FDA · Hematologic Malignancies · 10 min

Dr. Sarah Mitchell